Full name
NOVOPHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
Novopharma sp. z o.o.
Opolska 11-19, 52-010 Wrocław
TAX ID8992672510
Rate company:
Novopharma sp. z o.o.
TAX ID8992672510
KRS0000331768
Share capital5,000.00 zł
Not confirmed
address
Opolska 11-19, 52-010 Wrocław
Website
www.novopharma.plCategories
Main category
About us
This text has been translated automaticallyWe are a biotechnology company. We specialize in scientific research in the field of human nutrition, dietary supplementation and dermocosmetics. We are developing especially those areas of science that contribute to an effective and safe reduction of overweight, change of nutritional profiles and inhibition of changes and aging of skin cells.
The leading brand among our supplements is NOVOSLIM, a modern preparation supporting the slimming process, while for those who value a healthy lifestyle, we offer INULINA - a natural prebiotic in the purest form, made from chicory root.
We invite you to familiarize yourself with our offer on our website.
Register Data
NIP
8992672510
REGON
020998193
KRS
0000331768
Legal form
limited liability company
ALEO.com Registration Date
2018-07-31
Register Address
UL. OPOLSKA 11-19, 52-010 WROCŁAW
Date of registration in KRS
2009-06-18
Date of commencement of economic activity
2009-06-18
Act signature
WR.VI NS-REJ.KRS/12888/20/735/ADE
Website
www.novopharma.pl
Pkd codes
10.86.Z - Production of homogenized food products and diet food
47.91.Z - Intermediary retail sale, non-specialized
71.20.A - Food quality testing and analysis
72.11.Z - Scientific research and development activities
72.19.Z - Scientific research and development activities
Payer VAT status
Active
Vat list bank account(s)
PL15 1090 2398 0000 0001 3266 9413 
PL44 1090 2398 0000 0001 3266 9376 Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss)  | 260,2 | 23,1 | 8,7 | -62,3 |
EBITDA | 273,1 | 38,1 | 15,2 | -60,2 |
Short time liabilities | 50 | 71,2 | 117,8 | 65,4 |
Equity capital | 376,4 | 396,8 | 403,8 | 1,8 |
Operating profit (EBIT) | 264,8 | 29,3 | 11,2 | -61,9 |
Assets | 451 | 480,6 | 523,9 | 9 |
Net profit (loss) | 235,8 | 20,1 | 7 | -64,9 |
Cash | 305,4 | 305,1 | 353,2 | 15,8 |
Liabilities and provisions for liabilities | 74,6 | 83,9 | 120,1 | 43,3 |
Net income from sale | 805,9 | 249,6 | 200,4 | -19,7 |
Working assets | 451 | 480,6 | 523,9 | 9 |
Depreciation | 8,3 | 8,8 | 4 | -54,5 |
% | % | % | p.p. | |
Profitability of capital | 62,6 | 5,1 | 1,7 | -3,4 |
Equity capital to total assets | 83,5 | 82,6 | 77,1 | -5,5 |
Gross profit margin | 32,3 | 9,2 | 4,3 | -4,9 |
EBITDA Margin | 33,9 | 15,3 | 7,6 | -7,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 23 | 104 | 215 | 111 |
Current financial liquidity indicator | 9.017197608947754 | 6.749359130859375 | 4.449010372161865 | -2,3 |
Net dept to EBITDA | -1.0284041166305542 | -7.668229579925537 | -23.112329483032227 | -15,4 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download docx01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Activity report
Download pdfShow more (2)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
mille sapori plus sp zoo
Warszawa
Instytut Zdrowia
gdynia
"PIEROŻKI ZE STOLNICY" ZUZANNA KRUSZEWSKA
Ostrów Mazowiecka
Czeskie ciasto Marlenka
Katowice
IKRA
Suwałki
"AG FOODS" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
MIĘDZYRZECZE GÓRNE
HS HABIB SHAHID
Słonawy